Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Astaxanthin is a potent antioxidant carotenoid found in microalgae, yeast, salmon, and other seafood. Its use in the context of chemotherapy is primarily supported by preclinical and limited clinical evidence. Chemotherapy often causes significant oxidative stress and inflammation, leading to side effects such as fatigue, organ toxicity, and damage to healthy tissues. Astaxanthin's antioxidant properties may help counteract these effects by scavenging reactive oxygen species (ROS) and reducing oxidative damage. Several animal studies have demonstrated that astaxanthin can protect cells from chemotherapy-induced toxicity, such as cardiotoxicity associated with doxorubicin. Additionally, some in vitro studies suggest that astaxanthin can modulate immune responses and reduce inflammation, which may further support its potential to alleviate chemotherapy side effects.

However, human clinical data are sparse. A few small-scale trials and observational studies have reported improvements in markers of oxidative stress and inflammation in cancer patients taking astaxanthin, but robust, large-scale randomized controlled trials are lacking. Therefore, while there is a plausible scientific rationale and promising preliminary data, the overall strength of evidence is limited, and more research is needed to validate astaxanthin's efficacy in reducing chemotherapy side effects. Patients considering astaxanthin should consult their oncologist, as interactions with chemotherapy drugs have not been fully elucidated.

More about astaxanthin
More about Chemotherapy (reducing side effects)

Other ingredients used for Chemotherapy (reducing side effects)

Other health conditions supported by astaxanthin

Products containing astaxanthin